Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.
J Neurol
; 271(3): 1277-1285, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-37917233
Increasing evidence implicates endo-lysosomal dysfunction in frontotemporal dementia (FTD). 18 proteins were quantified using a mass spectrometry assay panel in the cerebrospinal fluid of 36 people with the language variant of FTD, primary progressive aphasia (PPA) (including 13 with non-fluent variant (nfvPPA), 11 with semantic variant (svPPA), and 12 with logopenic variant (lvPPA)) and 19 healthy controls. The concentrations of the cathepsins (B, D, F, L1, and Z) as well as AP-2 complex subunit beta, ganglioside GM2 activator, beta-hexosaminidase subunit beta, tissue alpha L-fucosidase, and ubiquitin were decreased in nfvPPA compared with controls. In contrast, the concentrations of amyloid beta A4 protein, cathepsin Z, and dipeptidyl peptidase 2 were decreased in svPPA compared with controls. No proteins were abnormal in lvPPA. These results indicate a differential alteration of lysosomal proteins in the PPA variants, suggesting those with non-Alzheimer's pathologies are more likely to show abnormal lysosomal function.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Afasia Primária Progressiva
/
Demência Frontotemporal
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article